﻿<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>BioSpectrum Asia - RSS Feed</title>
    <link>http://biospectrumasia.ciol.com/rss/</link>
    <description>BioSpectrum Asia is a specialized information platform for life science articles in the Asia Pacific that includes life sciences articles, pharma news, life science products reviews and other information</description>
    <language>en-us</language>
    <pubDate>2/4/2012 10:01:12 AM</pubDate>
    <lastBuildDate>2/4/2012 10:01:12 AM</lastBuildDate>
    <docs>http://biospectrumasia.ciol.com/rss/</docs>
    <generator>BSA Feed Generator</generator>
    <managingEditor>sureshn@cybermedia.co.in</managingEditor>
    <webMaster>webmasterciol@cybermedia.co.in</webMaster>
    <item>
      <title>Renaissance in genomics with next generation sequencing</title>
      <link>http://www.biospectrumasia.com/content/030212IND18154.asp</link>
      <description>Next Generation Sequencing (NGS) is currently the biggest buzzword in the field of genomics</description>
      <pubDate>2/3/2012 5:28:24 PM</pubDate>
      <guid>http://www.biospectrumasia.com/content/030212IND18154.asp</guid>
    </item>
    <item>
      <title>Starpharma releases animal data for dendrimer-docetaxel formulation</title>
      <link>http://www.biospectrumasia.com/content/030212AUS18153.asp</link>
      <description>Starpharma Holdings released animal data which demonstrated that its dendrimer-docetaxel formulation applying Starpharmas dendrimer technology to the leading chemotherapy drug docetaxel was more efficacious than docetaxel in a breast cancer model</description>
      <pubDate>2/3/2012 11:32:41 AM</pubDate>
      <guid>http://www.biospectrumasia.com/content/030212AUS18153.asp</guid>
    </item>
    <item>
      <title>REGiMMUNE begins phase I/II study of RGI-2001</title>
      <link>http://www.biospectrumasia.com/content/030212JPN18152.asp</link>
      <description>REGiMMUNE said it has begun a phase I/II study of its proprietary compound RGI-2001 for Graft versus Host Disease associated with hematopoietic stem cell transplantation</description>
      <pubDate>2/3/2012 11:22:56 AM</pubDate>
      <guid>http://www.biospectrumasia.com/content/030212JPN18152.asp</guid>
    </item>
    <item>
      <title>Prana comments on three scientific journal articles</title>
      <link>http://www.biospectrumasia.com/content/030212AUS18151.asp</link>
      <description>Prana Biotechnology commented on three recent high profile scientific journal articles that the company believes provide support for Pranas therapeutic strategy for treating neurodegenerative disease</description>
      <pubDate>2/3/2012 11:14:42 AM</pubDate>
      <guid>http://www.biospectrumasia.com/content/030212AUS18151.asp</guid>
    </item>
    <item>
      <title>CVS/pharmacy launches product for prescription text alerts</title>
      <link>http://www.biospectrumasia.com/content/030212OTH18150.asp</link>
      <description>CVS/pharmacy announced the launch of Order Ready Text Messaging, which can enroll in the program to receive immediate notification via text message when their prescription is ready to be picked up</description>
      <pubDate>2/3/2012 10:54:27 AM</pubDate>
      <guid>http://www.biospectrumasia.com/content/030212OTH18150.asp</guid>
    </item>
    <item>
      <title>FDA and industry agree on medical device user fees</title>
      <link>http://www.biospectrumasia.com/content/030212OTH18149.asp</link>
      <description>The FDA and representatives from the medical device industry have reached an agreement in principle on proposed recommendations for the third reauthorization of a medical device user fee program</description>
      <pubDate>2/3/2012 10:32:46 AM</pubDate>
      <guid>http://www.biospectrumasia.com/content/030212OTH18149.asp</guid>
    </item>
    <item>
      <title>PAREXEL collaborates with Korea''s ASAN Medical</title>
      <link>http://www.biospectrumasia.com/content/030212KOR18148.asp</link>
      <description>PAREXEL international has entered into an agreement with ASAN Medical Center, based in Seoul, Korea</description>
      <pubDate>2/3/2012 10:29:21 AM</pubDate>
      <guid>http://www.biospectrumasia.com/content/030212KOR18148.asp</guid>
    </item>
    <item>
      <title>Bangalore India Bio 2012 to focus on emerging bioeconomies</title>
      <link>http://www.biospectrumasia.com/content/020212IND18147.asp</link>
      <description>Bangalore INDIA BIO will feature multi-track conference, international trade show, India''s Biotech Vision 2015 Leadership Series, BioPartnering India, podium presentations, poster session, CEO conclave, Bio Excellence Awards and BioQuiz</description>
      <pubDate>2/2/2012 4:53:25 PM</pubDate>
      <guid>http://www.biospectrumasia.com/content/020212IND18147.asp</guid>
    </item>
    <item>
      <title>Dr Peter Nightingale appointed president of Acoris Research</title>
      <link>http://www.biospectrumasia.com/content/020212IND18146.asp</link>
      <description>Hikal announced the appointment of Dr Peter Nightingale as the President of its 100% Contract Research subsidiary, Acoris Research, Pune, India</description>
      <pubDate>2/2/2012 4:27:28 PM</pubDate>
      <guid>http://www.biospectrumasia.com/content/020212IND18146.asp</guid>
    </item>
    <item>
      <title>Brookfield Engineering Laboratories inaugurates lab in India</title>
      <link>http://www.biospectrumasia.com/content/020212IND18145.asp</link>
      <description>Apart from the Indian market, the lab will also serve customers in West Asia, Africa and the ASEAN nations as a knowledge resource centre for Viscosity, Rheology and Powder Flow Analysis</description>
      <pubDate>2/2/2012 4:23:35 PM</pubDate>
      <guid>http://www.biospectrumasia.com/content/020212IND18145.asp</guid>
    </item>
    <item>
      <title>GE invests in development of ingestible imaging capsule</title>
      <link>http://www.biospectrumasia.com/content/020212OTH18144.asp</link>
      <description>GE Capital and GE Healthcare announced an investment in Check-Cap, a developer of an ingestible imaging capsule that may help detect colorectal cancer</description>
      <pubDate>2/2/2012 4:19:22 PM</pubDate>
      <guid>http://www.biospectrumasia.com/content/020212OTH18144.asp</guid>
    </item>
    <item>
      <title>Sigma Aldrich launches product made from fungus found in Thailand</title>
      <link>http://www.biospectrumasia.com/content/020212THA18143.asp</link>
      <description>Sigma Aldrich recently launched a new product, Ascochlorin, which has been derived from a fungus found in Thailand called Verticillium hemipterigenum</description>
      <pubDate>2/2/2012 4:11:51 PM</pubDate>
      <guid>http://www.biospectrumasia.com/content/020212THA18143.asp</guid>
    </item>
    <item>
      <title>Sigma-Aldrich acquires BioReliance</title>
      <link>http://www.biospectrumasia.com/content/020212IND18142.asp</link>
      <description>Sigma-Aldrich has completed its acquisition of  BioReliance Holdings, a leading provider of global biopharmaceutical testing services, from Avista Capital Partners for $350 million in cash, subject to normal post-closing adjustments</description>
      <pubDate>2/2/2012 9:31:52 AM</pubDate>
      <guid>http://www.biospectrumasia.com/content/020212IND18142.asp</guid>
    </item>
    <item>
      <title>$10 million grant for Dana-Farbers cancer research program</title>
      <link>http://www.biospectrumasia.com/content/020212US18141.asp</link>
      <description>Massachusetts Life Sciences Center has awarded Boston-based Dana-Farber Cancer Institute a $10 million grant to support the expansion of its pioneering cancer imaging research program</description>
      <pubDate>2/2/2012 9:18:59 AM</pubDate>
      <guid>http://www.biospectrumasia.com/content/020212US18141.asp</guid>
    </item>
    <item>
      <title>FDA approves Novartis drug Glivec</title>
      <link>http://www.biospectrumasia.com/content/020212OTH18140.asp</link>
      <description>FDA has approved an update to the Glivec (imatinib) label by Novartis to recommend 36 months of treatment after surgery for adult patients with KIT (CD117)-positive gastrointestinal stromal tumors</description>
      <pubDate>2/2/2012 9:11:13 AM</pubDate>
      <guid>http://www.biospectrumasia.com/content/020212OTH18140.asp</guid>
    </item>
  </channel>
</rss>
